|
|
|
|
|
|
Companies > Clinical
|
|
|
Renovo Neural Inc. (RNI) is mastering the next frontier in drug development for Multiple Schlerosis (MS): Remyelination. RNI has been developing its remyelination assays since the company's founding in mid-2008 and has offered them commercially since mid-2010.
|
|
|
|
|